biostudies-literatureSun Xthe 2018 Medical and Health Research Projects in Zhejiang Province380https://www.ebi.ac.uk/biostudies/studies/S-EPMC9720910biostudies-literatureUnknown20(1)<h4>Objective</h4>To screen out potential biomarkers by analyzing fundamental nutrients in the bronchoalveolar lavage fluid (BALF) before confirming the lung cancer.<h4>Methods</h4>In this study, 44 patients were enrolled with clinical information. The concentrations of 23 amino acids and 35 carnitines in their BALF were detected with the high-performance liquid chromatography-mass spectrometry (HPLC-MS). Combined with clinicopathological diagnosis, the patients were divided into the lung cancer group (grades I & II and III & IV) and the non-cancer group for standard statistical analysis.<h4>Results</h4>The partial least squares-discriminant analysis (PLS-DA), the Shapiro-Wilk test, and the Bonferroni correction results showed that the serine concentration was higher and the butane-diacyl-carnitine (C4DC) concentration was lower in the lung cancer group, further showing the same changing trend continuously through the non-cancer stage, grades I & II stage and grades III & IV stage. Those two potential biomarkers have been identified.<h4>Conclusion</h4>The HPLC-MS target detection in clinic for nutrient concentration levels is a promising technique to find the changing concentration of serine and C4DC in BALF, which provides an economical and practical way for early warning of lung cancer.World journal of surgical oncologyThe amino acid and carnitine concentration changes in bronchoalveolar lavage fluid from lung cancer patients.PMC97209102018KY837Xu LYang GShan YXu MZhu YChen XSun XKong JDing LXu YfalseThe amino acid and carnitine concentration changes in bronchoalveolar lavage fluid from lung cancer patients.<h4>Objective</h4>To screen out potential biomarkers by analyzing fundamental nutrients in the bronchoalveolar lavage fluid (BALF) before confirming the lung cancer.<h4>Methods</h4>In this study, 44 patients were enrolled with clinical information. The concentrations of 23 amino acids and 35 carnitines in their BALF were detected with the high-performance liquid chromatography-mass spectrometry (HPLC-MS). Combined with clinicopathological diagnosis, the patients were divided into the lung cancer group (grades I & II and III & IV) and the non-cancer group for standard statistical analysis.<h4>Results</h4>The partial least squares-discriminant analysis (PLS-DA), the Shapiro-Wilk test, and the Bonferroni correction results showed that the serine concentration was higher and the butane-diacyl-carnitine (C4DC) concentration was lower in the lung cancer group, further showing the same changing trend continuously through the non-cancer stage, grades I & II stage and grades III & IV stage. Those two potential biomarkers have been identified.<h4>Conclusion</h4>The HPLC-MS target detection in clinic for nutrient concentration levels is a promising technique to find the changing concentration of serine and C4DC in BALF, which provides an economical and practical way for early warning of lung cancer.2022-01-01T00:00:00Z2022 Dec2025-04-26T11:59:44.531Z2025-02-19T04:34:08.341ZS-EPMC97209103646470310.1186/s12957-022-02850-5